Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Davide Mileto and Giuliano Rizzardini.
Davide Mileto
Connection Strength
0.818
Giuliano Rizzardini
  1. Impressive Boosting of Anti-S1/S2 Immunoglobulin G Production in Coronavirus Disease 2019 (COVID-19)-experienced Patients After the First Shot of the BNT162b2 Messenger RNA COVID-19 Vaccine. Clin Infect Dis. 2021 09 15; 73(6):e1402-e1403.
    View in: PubMed
    Score: 0.242
  2. One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG. J Infect. 2021 08; 83(2):237-279.
    View in: PubMed
    Score: 0.237
  3. A case of extremely prolonged viral shedding: Could cell cultures be a diagnostic tool to drive COVID-19 patient discharge? Int J Infect Dis. 2021 Mar; 104:631-633.
    View in: PubMed
    Score: 0.229
  4. Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy. Eur J Intern Med. 2020 06; 76:36-42.
    View in: PubMed
    Score: 0.055
  5. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Pharmacol Res. 2020 08; 158:104899.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.